Company: HUM
Filing Date: 2025-03-03
Form Type: 8-K
Source: 0000049071-25-000009
Chunk: 0

Company: HUMANA INC
Filing Date: 2025-03-03
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01

Regulation FD Disclosure.

Members of Humana Inc.’s (the “ Company”) senior management team are scheduled to meet with investors and analysts at various meetings between March 3, 2025 and March 31, 2025. During these meetings, the Company intends to reaffirm its guidance of approximately $15.88 in diluted earnings per common share (“ EPS”) or approximately $16.25 in adjusted earnings per common share (“ Adjusted EPS”), in each case for the year ending December 31, 2025 (“ FY 2025”). This guidance is consistent with the guidance issued in Humana’s press release dated February 11, 2025.

The Company has included Adjusted EPS in this current report, a financial measure that is not in accordance with Generally Accepted Accounting Principles (“ GAAP”). Management believes that this measure, when presented in conjunction with the comparable measure of GAAP EPS, provides a comprehensive perspective to more accurately compare and analyze the Company’s core operating performance over time. Consequently, management uses Adjusted EPS as a consistent and uniform indicator of the Company’s core business operations from period to period, as well as for planning and decision-making purposes and in determination of incentive compensation. Adjusted EPS should be considered in addition to, but not as a substitute for, or superior to, GAAP EPS. A reconciliation of GAAP EPS to Adjusted EPS follows:

  Diluted earnings per common share                      FY 2025 Guidance      
  GAAP                                                   approximately $15.88  
  Amortization of identifiable intangibles               0.49                  
  Cumulative net tax impact of non-GAAP adjustments      (0.12)                
  Adjusted (non-GAAP) – FY 2025 projected                approximately $16.25  

Cautionary Statement

This Current Report on Form 8-K includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, generally including the words or phrases like “expects,” “believes,” “anticipates,” “intends,” “likely will result,” “estimates,” “projects” or variations of such words and similar expressions that are intended to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the “ Risk Factors” section of the Company’s SEC filings.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 193